These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34121836)

  • 21. Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.
    Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M
    Glob J Health Sci; 2015 Jun; 8(3):59-64. PubMed ID: 26493438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
    Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
    Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxychloroquine retinopathy.
    Yusuf IH; Sharma S; Luqmani R; Downes SM
    Eye (Lond); 2017 Jun; 31(6):828-845. PubMed ID: 28282061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
    Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
    Intern Med; 2019 May; 58(9):1257-1262. PubMed ID: 30626831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus.
    Lee JE; Nam DR; Sung YK; Kim YJ; Jung SY
    Sci Rep; 2023 May; 13(1):7270. PubMed ID: 37142639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal Complications in Patients with Systemic Lupus Erythematosus Treated with Antimalarial Drugs.
    Mukwikwi ER; Pineau CA; Vinet E; Clarke AE; Nashi E; Kalache F; Grenier LP; Bernatsky S
    J Rheumatol; 2020 Apr; 47(4):553-556. PubMed ID: 31474597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
    Greenstein VC; Lima de Carvalho JR; Parmann R; Amaro-Quireza L; Lee W; Hood DC; Tsang SH; Sparrow JR
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):41. PubMed ID: 32976563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
    Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
    Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine retinopathy: an emerging problem.
    Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
    Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
    Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
    Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.
    Hong EH; Ahn SJ; Lim HW; Lee BR
    BMC Ophthalmol; 2017 Jul; 17(1):124. PubMed ID: 28701214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
    Manoj M; Sahoo RR; Singh A; Hazarika K; Bafna P; Kaur A; Wakhlu A
    Rheumatol Int; 2021 May; 41(5):929-937. PubMed ID: 33704526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
    J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment.
    Ozawa H; Ueno S; Ohno-Tanaka A; Sakai T; Hashiguchi M; Shimizu M; Fujinami K; Ahn SJ; Kondo M; Browning DJ; Shinoda K; Yokogawa N
    Jpn J Ophthalmol; 2021 Jul; 65(4):472-481. PubMed ID: 34014447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
    Debellemanière G; Flores M; Tumahai P; Meillat M; Bidaut Garnier M; Delbosc B; Saleh M
    Acta Ophthalmol; 2015 Nov; 93(7):e534-40. PubMed ID: 25989823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
    Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
    Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.